Contribution of intestinal epithelial cells to innate immunity of the human gut--studies on polarized monolayers of colon carcinoma cells.
The aim was to establish an in vitro model for studies of innate defence mechanisms of human intestinal epithelium. Ultrastructural characterization and determination of mRNA expression levels for apical glycocalyx and mucous components showed that polarized, tight monolayers of the colon carcinoma cell lines T84 and Caco2 acquire the features of mature- and immature columnar epithelial cells, respectively. Polarized monolayers were challenged with non-pathogenic Gram+ and Gram- bacteria from the apical side and the proinflammatory cytokines interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) from the basolateral side. Immune responses were estimated as changes in mRNA expression levels for the mucous component mucin-2 (MUC2), the glycocalyx components carcinoembryonic antigen (CEA), CEA-related cell adhesion molecule-1 (CEACAM1), CEACAM6, CEACAM7 and MUC3, the antimicrobial factors human beta-defensin-1 (hBD1), hBD2, hBD3 and lysozyme, the chemokine IL-8 and the cytokines IL-6 and TNF-alpha. Tight monolayer cells were generally unresponsive to bacterial challenge, but increased their hBD2 levels when challenged with Bacillus megaterium. T84 cells also increased their TNF-alpha levels upon bacterial challenge. Tight monolayer cells responded to cytokine challenge suggesting awareness of basolateral attack. TNF-alpha induced significantly increased levels of IL-8 and TNF-alpha itself in both cell lines suggesting recruitment and activation of immune cells in the underlying mucosa in vivo. Cytokine challenge also increased levels of CEACAM1, which includes two functionally different forms, CEACAM1-L and CEACAM1-S. In T84 cells, IFN-gamma was selective for CEACAM1-L while TNF-alpha upregulated both forms. Increased CEACAM1 expression may influence epithelial function and communication between epithelial cells and intraepithelial lymphocytes.
Ou
G
G
Department of Clinical Microbiology, Immunology, Umeå University, Umeå, Sweden.
Baranov
V
V
Lundmark
E
E
Hammarström
S
S
Hammarström
M-L
ML
D015703:Antigens, CD / Q000235:genetics; D018938:Caco-2 Cells; D002272:Carcinoembryonic Antigen / Q000235:genetics; D015815:Cell Adhesion Molecules / Q000235:genetics; D016764:Cell Polarity; D003110:Colonic Neoplasms / Q000276:immunology*; D016207:Cytokines / Q000235:genetics; D004847:Epithelial Cells / Q000276:immunology; D058851:GPI-Linked Proteins; D020869:Gene Expression Profiling; D006801:Humans; D007113:Immunity, Innate; D007413:Intestinal Mucosa / Q000166:cytology / Q000276:immunology*; D007422:Intestines / Q000276:immunology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D055263:Mucin-3 / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis
D015703:Antigens, CD; C069847:CD66 antigens; C091223:CEACAM7 protein, human; D002272:Carcinoembryonic Antigen; D015815:Cell Adhesion Molecules; D016207:Cytokines; D058851:GPI-Linked Proteins; D008070:Lipopolysaccharides; C524652:MUC3A protein, human; D055263:Mucin-3; D012333:RNA, Messenger